Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
14.18
-0.11 (-0.77%)
Nov 27, 2023, 4:00 PM EST - Market closed
Pliant Therapeutics Stock Forecast
Stock Price Forecast
According to 11 stock analysts, the average 12-month stock price forecast for PLRX stock stock is $48.45, which predicts an increase of 241.68%. The lowest target is $33 and the highest is $63. On average, analysts rate PLRX stock stock as a strong buy.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PLRX stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '23 | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 7 | 7 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $54 → $53 | Buy | Maintains | $54 → $53 | +273.77% | Nov 10, 2023 |
| Needham | Needham | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +217.35% | Oct 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $50 → $52 | Strong Buy | Maintains | $50 → $52 | +266.71% | Sep 27, 2023 |
| Needham | Needham | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +217.35% | Sep 27, 2023 |
| Needham | Needham | Strong Buy Reiterates $45 | Strong Buy | Reiterates | $45 | +217.35% | Sep 15, 2023 |
Financial Forecast
Revenue This Year
2.52M
from 9.69M
Decreased by -74.03%
Revenue Next Year
1.12M
from 2.52M
Decreased by -55.55%
EPS This Year
-3.02
from -2.94
EPS Next Year
-3.51
from -3.02
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 9.5M | 5.3M | 21.0M | 21.0M | 199.8M |
| Avg | 2.5M | 1.1M | 3.4M | 4.8M | 55.5M |
| Low | 1.5M | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -2.4% | 108.7% | 1,778.4% | 520.9% | 4,089.3% |
| Avg | -74.0% | -55.5% | 202.5% | 41.0% | 1,064.3% |
| Low | -84.0% | - | - | - | - |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -2.90 | -3.13 | -2.88 | -3.12 | -0.86 |
| Avg | -3.02 | -3.51 | -3.69 | -4.01 | -3.30 |
| Low | -3.22 | -4.59 | -5.29 | -5.93 | -5.30 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.